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OBJECTIVES The goal of this study was to determine the presentation and outcome of the unoperated adult
with congenitally corrected transposition of the great arteries.
BACKGROUND The presentation of this disorder and the outcome in unoperated adults have not been well
defined.
METHODS All unoperated patients 18 years old were evaluated for spectrum of disease, hemodynamic
severity, timeliness of diagnosis and referral, and outcome.
RESULTS Forty-four patients aged 20 to 79 years (mean, 44) were followed up to 144 months. In 29
(66%), the correct diagnosis was first made at age 18 years; the diagnosis was missed in
seven of these patients in a prior cardiology consultation, despite cardiac imaging. Systemic
atrioventricular valve (SAVV) regurgitation (grade 3/4) was noted in 26 patients (59%).
Thirty (68%) had surgical intervention, including SAVV replacement in all, with no early
mortality. Preoperatively, this subset had significant dysfunction of the systemic ventricle
(SV) (ejection fraction [EF], 40  10%), and most had advanced symptoms (25 with ability
index 2/4). In 16 (53%), SAVV regurgitation 3/4 and ventricular dysfunction had been
documented for 6 months. The mean EF of the SV decreased significantly postoperatively
(34 11%, p 0.006). Four patients (13%) eventually required cardiac transplantation. Poor
preoperative EF of the SV predicted eventual need for transplantation (p  0.001).
CONCLUSIONS Patients with unoperated congenitally corrected transposition of the great arteries are often
misdiagnosed in adulthood and are referred late despite symptomatic SAVV regurgitation
and significant SV dysfunction. Although excellent early surgical results can be achieved,
significant residual dysfunction of the SV is common. (J Am Coll Cardiol 2002;40:285–90)
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Congenitally corrected transposition of the great arteries
(CTGA) is a complex congenital cardiac anomaly with a
wide spectrum of morphologic features and clinical profiles
(1,2). For all cases, the shared underlying abnormality
consists of atrioventricular and ventriculoarterial discor-
dance. The morphologic right ventricle functions as the
systemic ventricle (SV), whereas the morphologic left ven-
tricle functions as the pulmonary ventricle (PV). The
atrioventricular valve connected to the SV is morphologi-
cally tricuspid and may also be designated as the systemic
atrioventricular valve (SAVV). The atrioventricular valve
connected to the PV is morphologically mitral and may be
designated as the pulmonary atrioventricular valve (PAVV).
The nature and extent of associated anomalies, including
SAVV regurgitation, dictate the need for and timing of
surgical intervention in the pediatric population (3). Long-
term outcomes have been described in this cohort as they
reach adulthood (3–5). In a proportion of patients, the
hemodynamics do not require surgical attention during
childhood, and, in some, the correct diagnosis is not
established until adulthood. We sought to characterize the
clinical characteristics of the unoperated adult with CTGA
referred to a large adult congenital heart disease clinic and to
describe the early and midterm outcomes in those under-
going subsequent surgical intervention.
METHODS
Patients. We searched the Mayo Clinic adult congenital
heart disease clinic database from 1986 to 2000 for all
CTGA patients 18 years old with two good-sized ventri-
cles and no prior cardiac surgery. Details regarding initial
symptoms, functional status and management before refer-
ral to the adult congenital heart disease clinic were obtained
through chart review. Surgical notes were reviewed, as were
imaging studies, with emphasis on the function of the SV
preoperatively and postoperatively. When multiple postop-
erative determinations of ejection fraction (EF) were made
at various times, we chose the study closest to 12 months
postoperatively to allow optimal ventricular recovery. The
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EF was determined echocardiographically (6). Grading of
SAVV regurgitation was semiquantitative (1/4 mild, 2/4
moderate, 3/4 moderately severe, 4/4 severe). Ability index
was graded with the Warnes-Somerville index, which em-
phasizes limitations in daily activity (7). Functional capacity
on the treadmill using time achieved on the Bruce protocol
was expressed as a percent of expected when compared with
the predicted value for gender, age and body size (8). A
patient was deemed to have been referred late if both of the
following two criteria were met: 1) documented SAVV
regurgitation 3/4 for more than six months, and 2)
documented symptoms of heart failure or SV EF 45% for
more than six months. Questionnaires were sent to selected
patients when initial retrieval of data from the chart review
was deemed insufficient or was not available in the last year.
The study protocol and questionnaire were reviewed and
approved by the Institutional Review Board.
Statistical methods. Mean, median, SD and range were
calculated for continuous variables. Frequencies were de-
rived for categorical variables. Unpaired continuous vari-
ables were compared by the Mann-Whitney U test. Paired
continuous variables were analyzed with the Wilcoxon test.
Categorical variables were compared by the Fisher exact
test. Prespecified variables were analyzed by proportional
hazards regression analysis as predictors of need for subse-
quent cardiac transplantation and included age at surgery.
All calculated p values were two-sided, and p values less
than 0.05 were considered statistically significant. Statistical
analysis was performed with JMP 4.04 (SAS Institute Inc.,
Cary, North Carolina).
RESULTS
Patient population. From our database we identified 73
subjects who fulfilled all of the following criteria: 1) diag-
nosis of CTGA with two good-sized ventricles, 2) seen at
least once during the 1986 to 2000 period, and 3)18 years
old at the time of the initial visit. From this group, 44
patients (22 of them men; mean age, 44 years; range, 20 to
79 years) had no history of cardiac surgery at the time of the
initial visit. All were referred to our clinic from another
consultant (cardiologist or internist) for further evaluation.
Recent (1 year) follow-up data were available in all cases.
The mean follow-up was 53 months (range, two to 144
months). The correct diagnosis of CTGA was made in
adult life (age18 years) in 29 of the 44 patients (66%), five
(17%) of whom were 60 years of age at the time of
diagnosis. In seven (24%) of the 29, the presence of a
congenital cardiac anomaly was not recognized despite prior
cardiology consultations elsewhere, which included in all at
least one cardiac imaging study (either echocardiogram or
catheterization or both). Of the 44 patients, 30 had surgical
intervention. Fourteen have remained unoperated (Fig. 1).
Initial presentation data. The presence of typical associ-
ated lesions (defined as PV outflow obstruction, ventricular
septal defect or morphologically abnormal SAVV) was
common, having been found in 22 of the 44 patients (50%)
(Table 1). Systemic atrioventricular valve regurgitation
(grade 3/4) was present in 26 patients (59%). In 16 of the
26 patients, the valve was morphologically abnormal (12
apically displaced, four not apically displaced but dysplastic).
Fourteen had PV outflow tract stenosis, three with peak
gradients 70 mm Hg. In two of the three patients, the
outflow obstruction was primarily related to a ventricular
septal aneurysm projecting into the outflow tract. In the
remaining patient, obstruction was due to a duplicated
SAVV crossing the ventricular septal defect.
The presenting symptoms varied; the most common
primary complaint was dyspnea, in 20 patients. No patient
Abbreviations and Acronyms
CTGA  congenitally corrected transposition of the
great arteries
EF  ejection fraction
PAVV  pulmonary atrioventricular valve
PV  pulmonary ventricle
SAVV  systemic atrioventricular valve
SV  systemic ventricle
Figure 1. Flow chart describing outcome of patients who presented with
unoperated congenitally corrected transposition of the great arteries
(CTGA).
Table 1. Spectrum of Disease at First Presentation (n  44)
n %
Cyanosis 0 0
Dextrocardia 7 16
Presence of associated lesion* 22 50
PV outflow obstruction 14 32
Ventricular septal defect 9 20
SAVV regurgitation 3/4 26 59
Apical displacement of SAVV† 12 27
Dysplastic SAVV 4 9
Atrial septal defect 10 23
PAVV regurgitation 3/4 3 7
Aortic regurgitation 3/4 3 7
High-grade atrioventricular block 14 32
Prior permanent pacemaker 6 14
*Defined as PV outflow obstruction or ventricular septal defect or as morphologically
abnormal SAVV; †nonapically displaced but dysplastic.
PV  pulmonary ventricle; PAVV  pulmonary atrioventricular valve; SAVV 
systemic atrioventricular valve.
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was cyanosed. The ability index at presentation was 1 in 11
patients (25%), 2 in 23 patients (53%), 3 in 9 patients (21%)
and 4 in 1 patient (2%). The mean exercise capacity in 27
patients who had exercise stress testing was 79  26% of
predicted (range, 32% to 122%). The mean EF of the SV at
initial presentation was 41  10% (range, 23 to 65).
Surgical group. Thirty patients (68%) underwent surgical
intervention (median age, 44 years; range, 20 to 75; median
follow-up time after surgery was 51 months; range, 5 to
143). Patients requiring surgery had larger cardiothoracic
ratios on chest radiographs and tended to have lower EF of
the SV, the majority having 3/4 SAVV regurgitation
(Table 2). Thirteen of the 30 patients requiring surgery were
deemed to be too sick to undergo exercise stress testing at
the initial evaluation. In 16 of 30 patients (53%), referral for
surgical intervention was deemed late (patient known to
have both SAVV regurgitation3/4 and clinical ventricular
dysfunction for more than six months). The median time to
surgery from initial referral was one month (range, 1 to 47
months). All patients underwent SAVV replacement as part
of the surgical procedure, and 20 had other concomitant
cardiac repair (Table 3).
One patient had double-switch surgery (Mustard and
Rastelli procedure) and SAVV replacement at age 32. He
presented with severe PV outflow obstruction, a large
ventricular septal defect and severe SAVV regurgitation.
The preoperative EF of his SV was 33%; the EF of the SV
was 25% 18 months after the procedure.
There were no early postoperative deaths. Two patients
required implantation of a permanent pacemaker for heart
block that occurred postoperatively (30 days). Three
patients had internal defibrillators placed: one for nonsus-
tained ventricular tachycardia in the setting of a poorly
functioning SV one week after SAVV replacement, one for
ventricular fibrillation arrest two months after SAVV re-
placement and one for sustained ventricular tachycardia 15
years after SAVV replacement. The mean follow-up of the
postoperative group was 51 months. Four patients eventu-
ally required orthotopic heart transplantation (see the fol-
lowing text). One patient died of endometrial carcinoma
nine years after SAVV replacement.
The mean preoperative EF of the SV was 40  10%,
range, 23 to 65. The mean postoperative EF of the SV was
34 11% (n 29, range, 15 to 52, p 0.006; median time
of the study after surgery was 11 months) (Fig. 2). There
was no significant difference in the use of medications
(angiotensin-converting enzyme inhibitor, angiotensin II
receptor blocker, beta-adrenergic blocking agent) that
Table 2. Baseline Hemodynamics of Subjects Requiring Subsequent Surgical Intervention Versus
Medically Treated Subjects (n  44)
Subsequent Surgery (30) No Surgery (14) p Value
Age, median (range), yr 44 (20–75) 43 (20–79) 0.71
SV EF, mean  SD (range), % 40  10 (23–65) 43  8 (25–58) 0.16
SAVV regurgitation 3/4, no., % 24 (80) 2 (14) 0.0001
CT ratio, mean  SD, % 0.57  0.10 0.47  0.07 0.005
Ability index 2, no., % 25 (83) 8 (57) 0.13
Functional capacity, mean  SD, %* 74  27 87  24 0.37
Unable to do EST, no., %† 13 (43) 0 (0) 0.01
*Performance on cardiopulmonary testing, expressed as percent of expected when compared with predicted value for gender, age
and body size; †Patient too ill to undergo exercise stress testing (EST) at presentation.
CT ratio  cardiothoracic ratio measured on chest radiograph; SAVV  systemic atrioventricular valve; SV EF  ejection
fraction of the systemic ventricle.
Table 3. Surgical Data (n  30)
n %
Age, median (range), yrs 44 (20–75)
SAVV replacement 30 100
Atrial septal defect closure 5 17
Ventricular septal defect repair 6 20
PV outflow surgery 6 20
PAVV surgery 3 10
Aortic valve replacement 2 7
Double switch 1 3
Complications
Early postoperative mortality 0 0
PPM for heart block 2 7
Eventual cardiac transplantation* 4 13
Late mortality† 1 3
*After initial surgical repair; †Noncardiovascular death.
PPM  permanent pacemaker for heart block acquired within one month
postoperatively; PV  pulmonary ventricle; PAVV  pulmonary atrioventricular
valve; SAVV  systemic atrioventricular valve.
Figure 2. Mean preoperative ejection fraction (EF) of the systemic
ventricle (40  10%, range 23 to 65) versus mean postoperative ejection
fraction (34  11%, range 15 to 52), median time after surgery, 11 months
(1 to 66), p  0.006, n  29.
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would have an impact on ventricular performance in the
patients at the time of the preoperative versus the postop-
erative echocardiogram (preoperative 21/30 [70%] vs. post-
operative 18/30 [60%], p  NS).
Need for orthotopic heart transplantation. Of the 30
patients treated surgically, four eventually required ortho-
topic heart transplantation because of failure of the SV
(median time to transplantation after initial surgery was 56
months; range, 24 to 118; mean follow-up time, 51
months). Poor preoperative EF of the SV was the only
variable that predicted eventual need for heart transplanta-
tion (Table 4).
Nonsurgical group. No surgery was performed in 14
patients (median age, 43 years; range, 20 to 79). The mean
EF of the SV at presentation was 43  8%; range, 25 to 58.
One patient presented to the clinic at age 62 with severe SV
dysfunction, an EF of 25% and severe SAVV regurgitation.
His SV dysfunction was thought to preclude a good
long-term result after SAVV replacement, and so he was
evaluated for cardiac transplantation. He was lost to follow-
up, and died suddenly 12 months later. No autopsy was
performed. Two patients eventually required permanent
pacemaker insertion for chronotropic incompetence.
DISCUSSION
The adult with CTGA can present in various ways (9–11).
A number of these patients have had prior surgical repair in
childhood for associated lesions that were hemodynamically
significant. Some were correctly diagnosed in childhood but
did not require surgical intervention. A subset of patients is
correctly diagnosed for the first time only in adulthood. The
last two groups form the cohort of patients with unoperated
CTGA who are seen in the adult congenital heart disease
clinic. This is the first report to focus specifically on this
subset of patients with CTGA. Our data suggest that these
patients present unique diagnostic and therapeutic chal-
lenges.
Diagnostic issues. In 66% of the patients in our cohort,
the initial diagnosis of CTGA was first made in adulthood;
17% of them were 60 years or older at the time of diagnosis.
This high proportion of patients with delayed diagnoses can
be partly explained by: 1) the unoperated subset of patients
with CTGA is more likely to have been asymptomatic
during childhood and did not require medical attention, and
2) two-dimensional echocardiography not having been
available in the era involved. The modes of clinical presen-
tation were varied and were similar to those in prior reports
(11,12). The majority presented with symptoms related to
SAVV regurgitation, failing SV function or conduction
disease. In some, the diagnosis was made incidentally when
electrocardiography, chest radiography or echocardiography
was performed for other reasons (e.g., atypical chest pain).
In 24%, the diagnosis had been missed at the time of a prior
cardiology consultation, despite the use in all cases of
cardiac imaging (echocardiogram or catheterization or
both). A common scenario was the patient with dextrocar-
dia who was thought to have simple situs inversus totalis
and was not recognized as having CTGA. Because it is a
relatively rare lesion, CTGA may not be readily recognized
by the adult cardiologist who is untrained in congenital
heart disease.
SAVV regurgitation and SV dysfunction. The most com-
mon hemodynamic problem encountered in this cohort was
SAVV regurgitation in the setting of impaired SV function.
Of the 68% of patients who required surgical intervention,
all needed SAVV replacement as part of the surgical repair.
The relation between SAVV regurgitation and SV dysfunc-
tion in CTGA is complex and is not completely understood
(9,10,13–15). In the majority of patients with CTGA, the
SAVV is morphologically abnormal (16). With time, the
valve deteriorates, and there is increasing regurgitation (11).
This chronic volume load on the SV, in turn, leads to
annular and ventricular dilation, resulting in malcoaptation
and worsening regurgitation (17). In a study with a mean
follow-up of 20 years (13), the presence of a morphologi-
cally abnormal SAVV was the only predictor of severe
SAVV regurgitation, and severe SAVV regurgitation was
the only independent predictor of long-term survival in both
operated and unoperated patients with CTGA.
Systemic ventricle dysfunction in the adult with CTGA is
common, is age related and occurs more likely in the
presence of associated anomalies, history of heart block or
history of prior surgical intervention (9–11,18,19). Some
have proposed that the SV may not be intrinsically suited to
function as a long-term systemic pump in CTGA (18).
However, there have been occasional reports of elderly
patients (7th or 8th decade) with essentially normal function
of the SV, usually in the absence of associated lesions.
Although it is difficult to determine whether ventricular
dysfunction or SAVV regurgitation is the initial culprit,
evidence suggests that, in the absence of associated lesions,
primary SV failure is uncommon but is a frequent sequela to
SAVV regurgitation (13). Although unproven, it has been
our experience that the degree of SAVV regurgitation in
CTGA may be underestimated by echocardiography, and
its presence should be aggressively sought, if necessary with
cardiac catheterization, especially in patients with deterio-
rating SV or progressive enlargement of the cardiothoracic
Table 4. Variables Predicting Need for Eventual Orthotopic
Heart Transplantation in the Surgical Group*
Variable p Value
Age at surgery 0.26
Functional capacity† 0.77
Ability index 2 0.21
CT ratio 0.31
Preoperative SV EF 0.001
*After initial surgical repair, four patients eventually required orthotopic transplanta-
tion—proportional hazards regression; †Performance on exercise stress testing at
initial visit, expressed as percent of expected when compared with predicted value for
gender, age and body size.
CT ratio  cardiothoracic ratio measured on chest radiograph; SV EF  ejection
fraction of the systemic ventricle.
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ratio on chest radiographs. Other proposed mechanisms of
failing of the SV have included coronary perfusion mis-
match (20), volume load from prior shunts (14) and inad-
equate myocardial protection at the time of prior surgery.
Additional challenges include the difficulties of defining
normal function of the SV as a systemic pump in CTGA.
Traditionally, EF has been used, and reported values have
varied, depending on the technique used and the presence or
absence of the above-mentioned variables in the population
studied. In a study involving a small group of young,
asymptomatic patients with no associated lesions, the mean
EF of the SV was 48  4% by radionuclide angiocardio-
graphy, which was comparable to the EF of a nontransposed
right ventricle (21). Recently, Fredriksen and colleagues
(22), using the same technique in a different cohort consist-
ing of adults with CTGA, many of whom had a history of
surgical intervention, reported a mean increase of the EF of
the SV with exercise of only 2%, which was less than the
expected 5% (23).
Timing of surgical intervention. The most appropriate
timing of SAVV replacement in the CTGA patient remains
uncertain. The SV seems to tolerate the volume load of
SAVV regurgitation less well than the morphologic left
ventricle does with mitral regurgitation. In view of this, the
threshold for surgical intervention may be lower. In a series
from the Mayo Clinic (24), replacement of the SAVV when
the EF of the SV was less than 44% was associated with
poor early and late outcome, whereas all patients with a
preoperative EF greater than 44% survived operation and
lived over mid- to long-term follow-up. Current guidelines
have suggested SAVV replacement in CTGA when SAVV
regurgitation is moderately severe or severe, especially if
there are signs of ventricular dysfunction. In our cohort, the
subset of surgical patients had a preoperative mean EF of
the SV of 39%, which is markedly depressed considering
that the majority (80%) had a large volume load (SAVV
regurgitation 3/4).
In 53% of the patients, the referral for surgery was
inappropriately delayed. We suspect that this delay was due
to difficulties in assessing SV performance, to underestimat-
ing the degree of SAVV regurgitation and to lack of
appreciation of the vulnerability of the SV in CTGA.
Although the patients did well, with no early mortality in
this series with mid-term results, the relatively poor preop-
erative EF of the SV suggests that in many patients SV
dysfunction might progressively deteriorate over longer
follow-up (24). Indeed, four patients eventually required
heart transplantation, and the low preoperative EF of the
SV was the only predictive variable for this event. At our
institution, one of the clinical variables used to determine
optimal timing of SAVV replacement has been a limitation
in exercise capacity on stress testing. It has been our
experience that patients with adult congenital heart disease
tend to underestimate their functional limitations and that,
in many, objective evaluation with exercise stress testing
may document unexpected impairment in exercise capacity.
Our data did not show that functional capacity on exercise
stress testing was statistically different between the surgical
group and the nonsurgical patients; nor did it predict need
of future transplantation. This finding was partly related to
the bias introduced because 43% of patients in the surgical
group were too ill to undergo testing.
Study limitations. Limitations of this study include refer-
ral bias, small numbers and lack of generalization to other
centers. Our cohort probably does not represent the whole
population of adults with unoperated CTGA in the com-
munity because the patients with poor hemodynamics were
more likely to be referred for further evaluation and con-
sideration for surgery. This limits generalization of our data.
The small number of patients and the infrequency of
morbid end points precluded multivariate analysis and
underpowered certain variables such as ability index and
cardiothoracic ratio, which we believe may be of prognostic
value. Although our early surgical mortality was zero, this
may not be generalizable to other centers with less experi-
ence in the management of these complex patients.
Conclusions. The unoperated adult with CTGA is often
diagnosed late in life, and the condition, not uncommonly,
is unrecognized at an initial cardiology consultation. Sys-
temic atrioventricular valve regurgitation is the dominant
hemodynamic lesion in this group. At the time of referral
for surgical repair, the majority of these patients have
significant SV dysfunction with advanced symptoms. Al-
though excellent early surgical results can be achieved,
residual impairment of the SV is common and may even-
tually necessitate cardiac transplantation.
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